OncoCyte Corp (OCX)
2.66
-0.12
(-4.30%)
USD |
NASDAQ |
May 03, 16:00
2.69
+0.03
(+1.13%)
After-Hours: 20:00
OncoCyte Cash from Operations (Quarterly): -4.562M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.562M |
| September 30, 2023 | -2.259M |
| June 30, 2023 | -6.832M |
| March 31, 2023 | -9.672M |
| December 31, 2022 | -9.648M |
| September 30, 2022 | -11.40M |
| June 30, 2022 | -11.25M |
| March 31, 2022 | -13.28M |
| December 31, 2021 | -7.065M |
| September 30, 2021 | -10.98M |
| June 30, 2021 | -8.058M |
| March 31, 2021 | -9.835M |
| December 31, 2020 | -6.144M |
| September 30, 2020 | -6.005M |
| June 30, 2020 | -6.961M |
| March 31, 2020 | -6.87M |
| December 31, 2019 | -5.306M |
| September 30, 2019 | -4.851M |
| Date | Value |
|---|---|
| June 30, 2019 | -2.84M |
| March 31, 2019 | -6.718M |
| December 31, 2018 | -2.456M |
| September 30, 2018 | -2.483M |
| June 30, 2018 | -3.957M |
| March 31, 2018 | -2.753M |
| December 31, 2017 | -3.344M |
| September 30, 2017 | -3.47M |
| June 30, 2017 | -3.281M |
| March 31, 2017 | -3.29M |
| December 31, 2016 | -2.514M |
| September 30, 2016 | -1.034M |
| June 30, 2016 | -1.807M |
| March 31, 2016 | -2.167M |
| December 31, 2015 | -1.695M |
| September 30, 2015 | -1.386M |
| June 30, 2015 | -0.984M |
| March 31, 2015 | -0.164M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.28M
Minimum
Mar 2022
-2.259M
Maximum
Sep 2023
-7.569M
Average
-6.961M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| Fonar Corp | 4.071M |
| XWELL Inc | -3.201M |
| ProPhase Labs Inc | -0.213M |
| Applied DNA Sciences Inc | -3.758M |
| Veracyte Inc | 15.55M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.241M |
| Cash from Financing (Quarterly) | -0.03M |
| Free Cash Flow | -23.61M |
| Free Cash Flow Per Share (Quarterly) | -0.5838 |
| Free Cash Flow to Equity (Quarterly) | -4.826M |
| Free Cash Flow Yield | -116.1% |